基于机器学习算法的利奈唑胺致血小板减少症风险预测模型的建立。

IF 2.9 4区 医学
Jie Chi, Juan Wang, Heng Tang, Shengfu Wang, Zhifeng Chen
{"title":"基于机器学习算法的利奈唑胺致血小板减少症风险预测模型的建立。","authors":"Jie Chi, Juan Wang, Heng Tang, Shengfu Wang, Zhifeng Chen","doi":"10.1002/jcph.70054","DOIUrl":null,"url":null,"abstract":"<p><p>The research aimed to develop a validated model for predicting the risk of linezolid-induced thrombocytopenia (LIT). An XGBoost model and SelectFromModel method were used to screen the important factors. Based on the selected features, five models-Logistic Regression, XGBoost, Random Forest, Naive Bayes, and Support Vector Machine-were established. Finally, the model results were interpreted using SHAP. In this retrospective study, 187 patients were enrolled, and the incidence of LIT was 35.8%. An XGBoost model was established with good performance, in which the AUCs of the training set and validation set were all 0.9. The duration of linezolid treatment, ICU admission time, low baseline platelet level, shock, and concomitant use of piperacillin-tazobactam were significant risk factors for LIT. A moderately raised level of platelet-large cell ratio, total bilirubin, and weight may help reduce the incidence of LIT.</p>","PeriodicalId":48908,"journal":{"name":"Journal of Clinical Pharmacology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of a Risk Prediction Model for Linezolid-Induced Thrombocytopenia Based on the Machine Learning Algorithm.\",\"authors\":\"Jie Chi, Juan Wang, Heng Tang, Shengfu Wang, Zhifeng Chen\",\"doi\":\"10.1002/jcph.70054\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The research aimed to develop a validated model for predicting the risk of linezolid-induced thrombocytopenia (LIT). An XGBoost model and SelectFromModel method were used to screen the important factors. Based on the selected features, five models-Logistic Regression, XGBoost, Random Forest, Naive Bayes, and Support Vector Machine-were established. Finally, the model results were interpreted using SHAP. In this retrospective study, 187 patients were enrolled, and the incidence of LIT was 35.8%. An XGBoost model was established with good performance, in which the AUCs of the training set and validation set were all 0.9. The duration of linezolid treatment, ICU admission time, low baseline platelet level, shock, and concomitant use of piperacillin-tazobactam were significant risk factors for LIT. A moderately raised level of platelet-large cell ratio, total bilirubin, and weight may help reduce the incidence of LIT.</p>\",\"PeriodicalId\":48908,\"journal\":{\"name\":\"Journal of Clinical Pharmacology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2025-07-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/jcph.70054\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/jcph.70054","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

该研究旨在建立一个有效的模型来预测利奈唑胺诱导的血小板减少症(LIT)的风险。使用XGBoost模型和SelectFromModel方法筛选重要因素。在选取特征的基础上,分别建立了logistic回归、XGBoost、随机森林、朴素贝叶斯和支持向量机5种模型。最后,使用SHAP对模型结果进行解释。本回顾性研究纳入187例患者,LIT发生率为35.8%。建立了性能良好的XGBoost模型,其中训练集和验证集的auc均为0.9。利奈唑胺治疗时间、ICU入院时间、基线血小板水平低、休克以及同时使用哌拉西林-他唑巴坦是LIT的重要危险因素。适度升高的血小板-大细胞比、总胆红素和体重水平可能有助于降低LIT的发生率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Development of a Risk Prediction Model for Linezolid-Induced Thrombocytopenia Based on the Machine Learning Algorithm.

The research aimed to develop a validated model for predicting the risk of linezolid-induced thrombocytopenia (LIT). An XGBoost model and SelectFromModel method were used to screen the important factors. Based on the selected features, five models-Logistic Regression, XGBoost, Random Forest, Naive Bayes, and Support Vector Machine-were established. Finally, the model results were interpreted using SHAP. In this retrospective study, 187 patients were enrolled, and the incidence of LIT was 35.8%. An XGBoost model was established with good performance, in which the AUCs of the training set and validation set were all 0.9. The duration of linezolid treatment, ICU admission time, low baseline platelet level, shock, and concomitant use of piperacillin-tazobactam were significant risk factors for LIT. A moderately raised level of platelet-large cell ratio, total bilirubin, and weight may help reduce the incidence of LIT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Clinical Pharmacology
Journal of Clinical Pharmacology PHARMACOLOGY & PHARMACY-
自引率
3.40%
发文量
0
期刊介绍: The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology. This includes original research in pharmacokinetics, pharmacogenetics/pharmacogenomics, pharmacometrics, physiologic based pharmacokinetic modeling, drug interactions, therapeutic drug monitoring, regulatory sciences (including unique methods of data analysis), special population studies, drug development, pharmacovigilance, womens’ health, pediatric pharmacology, and pharmacodynamics. Additionally, JCP publishes review articles, commentaries and educational manuscripts. The Journal also serves as an instrument to disseminate Public Policy statements from the American College of Clinical Pharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信